Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Volonté

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Case Reports in Dermatological Medicine|May 30, 2025
15 Years of Intermittent Therapy With Hydroxychloroquine Without Any Loss of Efficacy in Reticular Erythematous MucinosisNicolò Di Giuli, Alice Bonelli, Martina Volonté, et al.
Frontiers in Immunology|February 14, 2024
Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccineJanosch Railton, Martina Volonté, Eugenio Isoletta, et al.
Frontiers in Medicine|October 24, 2024
Cryptococcoid Sweet syndrome: a case reportMartina Volonté, Giacomo Fiandrino, Camilla Vassallo, et al.
International Journal of Women'S Dermatology|February 13, 2024
Lipschütz ulcers due to SARS-CoV-2 infection: a neglected diagnosis in emergency roomIlaria Brambilla, Vittorio Bolcato, Martina Volonté, et al.
European Journal of Dermatology : EJD|August 18, 2023
Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospitalMartina Volonté, Alessia Claudia Codazzi, Shay Davidovich, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Case Reports in Dermatological Medicine|May 30, 2025
15 Years of Intermittent Therapy With Hydroxychloroquine Without Any Loss of Efficacy in Reticular Erythematous MucinosisNicolò Di Giuli, Alice Bonelli, Martina Volonté, et al.
Frontiers in Immunology|February 14, 2024
Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccineJanosch Railton, Martina Volonté, Eugenio Isoletta, et al.
Frontiers in Medicine|October 24, 2024
Cryptococcoid Sweet syndrome: a case reportMartina Volonté, Giacomo Fiandrino, Camilla Vassallo, et al.
International Journal of Women'S Dermatology|February 13, 2024
Lipschütz ulcers due to SARS-CoV-2 infection: a neglected diagnosis in emergency roomIlaria Brambilla, Vittorio Bolcato, Martina Volonté, et al.
European Journal of Dermatology : EJD|August 18, 2023
Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospitalMartina Volonté, Alessia Claudia Codazzi, Shay Davidovich, et al.
Pageof 1